跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11 条关于
“TauRx”
全部
11
临床试验
1
药物
3
机构
2
资讯
5
去年
TauRx Secures $119 Million Investment as Novel Tau-Targeting Alzheimer's Drug Advances Toward Regulatory Filing
去年
TauRx's LMTX Shows Promising Results for Alzheimer's Treatment with Potential to Become First Oral Disease-Modifying Therapy
去年
Hydromethylthionine Mesylate: Oral Alzheimer's Drug Under NHS Consideration
9个月前
Johnson & Johnson's Posdinemab Fails Phase 2b Trial, Dealing Blow to Tau-Targeting Alzheimer's Therapies
10个月前
Bristol-Myers Squibb Exercises $2.2 Billion Option on Prothena's Tau-Targeting Alzheimer's Antibody